• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transl Neurodegener . SARS-CoV-2 membrane protein induces neurodegeneration via affecting Golgi-mitochondria interaction

tetano

Editor, Senior Moderator
Transl Neurodegener


. 2024 Dec 27;13(1):68.
doi: 10.1186/s40035-024-00458-1. SARS-CoV-2 membrane protein induces neurodegeneration via affecting Golgi-mitochondria interaction

Fang Wang[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Hailong Han[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Caifang Wang[SUP] 2 3 [/SUP], Jingfei Wang[SUP] 4 [/SUP], Yanni Peng[SUP] 2 3 [/SUP], Ye Chen[SUP] 2 3 [/SUP], Yaohui He[SUP] 5 [/SUP], Zhouyang Deng[SUP] 3 [/SUP], Fang Li[SUP] 3 [/SUP], Yikang Rong[SUP] 1 [/SUP], Danling Wang[SUP] 1 [/SUP], Wen Liu[SUP] 5 [/SUP], Hualan Chen[SUP] 4 [/SUP], Zhuohua Zhang[SUP] 6 7 8 [/SUP]



Affiliations
Abstract

Background: Neurological complications are a significant concern of Coronavirus Disease 2019 (COVID-19). However, the pathogenic mechanism of neurological symptoms associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is poorly understood.
Methods: We used Drosophila as a model to systematically analyze SARS-CoV-2 genes encoding structural and accessory proteins and identified the membrane protein (M) that disrupted mitochondrial functions in vivo. The M protein was stereotaxically injected to further assess its effects in the brains of wild-type (WT) and 5 × FAD mice. Omics technologies, including RNA sequencing and interactome analysis, were performed to explore the mechanisms of the effects of M protein both in vitro and in vivo.
Results: Systematic analysis of SARS-CoV-2 structural and accessory proteins in Drosophila identified that the M protein induces mitochondrial fragmentation and dysfunction, leading to reduced ATP production, ROS overproduction, and eventually cell death in the indirect flight muscles. In WT mice, M caused hippocampal atrophy, neural apoptosis, glial activation, and mitochondrial damage. These changes were further aggravated in 5 × FAD mice. M was localized to the Golgi apparatus and genetically interacted with four wheel drive (FWD, a Drosophila homolog of mammalian PI4KIIIβ) to regulate Golgi functions in flies. Fwd RNAi, but not PI4KIIIα RNAi, reversed the M-induced Golgi abnormality, mitochondrial fragmentation, and ATP reduction. Inhibition of PI4KIIIβ activity suppressed the M-induced neuronal cell death. Therefore, M induced mitochondrial fragmentation and apoptosis likely through disruption of Golgi-derived PI(4)P-containing vesicles.
Conclusions: M disturbs the distribution and function of Golgi, leading to mitochondrial abnormality and eventually neurodegeneration via a PI4KIIIβ-mediated mechanism. This study reveals a potential mechanism for COVID-19 neurological symptoms and opens a new avenue for development of therapeutic strategies targeting SARS-CoV-2 M or mitochondria.

Keywords: Alzheimer’s disease; Brain; COVID-19; Mitochondria; PI4KIIIβ.

 
Back
Top Bottom